Board approves grant of 3,037 Restricted Stock Units under ESOP Scheme 2021
Board of Jubilant Ingrevia approved the grant of 3,037 Restricted Stock Units to eligible employees under the Jubilant Ingrevia Employees Stock Option Scheme 2021.
By ScoutQuest · · 2 min read
- RSUs Granted
- 3,037 Restricted Stock Units
- Exercise Price
- Re. 1/- each
- Vesting Schedule
- vest at the end of the 3rd year and can be exercised within one year of vesting
What was approved
The Board of Jubilant Ingrevia met on Tuesday, October 27, 2026, from 11:10 a.m. to 02:00 p.m., and approved the grant of 3,037 Restricted Stock Units (RSUs) to eligible employees under the Jubilant Ingrevia Employees Stock Option Scheme 2021. The grant was determined by the Nomination, Remuneration and Compensation Committee.
Key terms of the grant
- Total RSUs granted: 3,037, covering 3,037 equity shares of face value Re. 1/- each.
- Exercise price: Re. 1/- per share, which is the face value of the equity share.
- Vesting: the RSUs vest at the end of the 3rd year from the grant.
- Exercise window: the options can be exercised within one year from vesting, subject to the terms of the scheme.
- Basis of grant: RSUs are granted based on the tenure and rating of the employee.
- The scheme is in terms of the SEBI (Share Based Employee Benefits) Regulations, 2021.
How to read this
Stock-based grants are part of employee compensation. Employees receive a right to buy shares at a fixed price, here Re. 1/- per share, once the vesting condition is met. Because the vesting is at the end of the 3rd year, the shares covered by this grant are linked to a future point in time rather than the present.
What to keep in mind
- The number of shares involved is 3,037, so the grant is a small, specific issuance tied to employee rewards.
- The exercise price of Re. 1/- per share is the face value, mentioned in the update as the pricing formula.
- The exercise window of one year runs from the vesting date, so the timing of any share issuance depends on when the RSUs vest and when employees choose to exercise.
Also from Jubilant Ingrevia
Jubilant Ingrevia uploads audio recording of Q2/H1 FY27 investors' conference call held October 27, 2026
27 Oct 2026
Jubilant Ingrevia Q2 FY27: Nutrition EBITDA up 87% YoY, Chemical Intermediates revenue up 24%; ZettaOne to build Bengaluru plant
27 Oct 2026
Jubilant Ingrevia reported revenue growth of 24%, with its chemical segment up 27% and nutrition and health segment up 51%, and net profit surging 61%
27 Oct 2026
More numbers
- Restricted Stock Units granted3,037 Restricted Stock Units
- Equity shares covered by the grant3,037 Equity Shares
- Face value per equity shareRe.1/-
- Exercise price per RSURe. 1/-
- Vesting period from grant3rd (third) year from the grant
- Exercise period from vestingone (1) year
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.